Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_assertion type Assertion NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_head.
- NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_assertion description "[However, a recent breakthrough indicates clinical efficacy of a drug stimulating the metabotropic glutamate receptor II, LY2140023, which has improved efficacy for negative and cognitive symptoms of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_provenance.
- NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_assertion evidence source_evidence_literature NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_provenance.
- NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_assertion SIO_000772 18759551 NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_provenance.
- NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_assertion wasDerivedFrom befree-2016 NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_provenance.
- NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_assertion wasGeneratedBy ECO_0000203 NP690777.RAxJX3wZmJEg3SUYOYSj9hkXrCpyFBaACT3jp4iDhnnqI130_provenance.